Skip to content

iRadimed IRMD Deferred revenue, net of current portion

Deferred revenue, net of current portion at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
ITG
Integer HoldingsITGR
ROP
Roper Technologies, Inc.ROP
Envista Holdings Corporation logo
Envista Holdings CorporationNVST

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.21B+63.4%
P/E51.3×+13.8×
P/S14×+4.2×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0.0×
Current ratio7.1×-1.7×

Where this comes from

Reported directly by iRadimed in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's deferred revenue, net of current portion.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's deferred revenue, net of current portion?
iRadimed (IRMD) reported deferred revenue, net of current portion of $3.76M in Q1 2026.
How has iRadimed's deferred revenue, net of current portion changed year-over-year?
iRadimed's deferred revenue, net of current portion increased by 17.3% year-over-year, from $3.2M to $3.76M.
What is the long-term trend for iRadimed's deferred revenue, net of current portion?
Over 5 years (2020 to 2025), iRadimed's deferred revenue, net of current portion has grown at a 11.5% compound annual growth rate (CAGR), from $2.31M to $3.98M.